Mitra Adiperkasa Tbk (MAPI)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 1,390.00 |
|---|---|
| 52-week range | 1,000.00 – 1,940.00 |
| Return, 1 month / 3 months | −7.9% / −8.3% |
| Return, 1 year / 3 years | +12.8% / −26.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 53.0% |
| Worst drawdown (1 year) | -35.1% |
| Average daily value traded | 16,500.61M IDR |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mitra Adiperkasa is an Indonesian retail company that brings international and domestic brands to shoppers across the country. It runs stores and food and beverage outlets covering fashion, sports, cosmetics, department stores and dining, working with global brand partners as well as its own concepts. Customers are mainly urban consumers in Indonesia's cities and shopping centres. The company is based in Jakarta and serves the Indonesian market through its retail network.
The shares are listed on the Jakarta Exchange in Indonesia under the code MAPI, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mitra Adiperkasa Tbk (MAPI) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,390.00 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 147 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.8% and over the last three months it fell 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | -26.6% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.3% | ||
| 6-month return | 7.2% | ||
| 12-month return, skipping the last month | 22.6% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.1% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 16,500.61M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | −7.9% |
| 3 months | −8.3% |
| 6 months | +7.2% |
| 1 year | +12.8% |
| 3 years | −26.1% |
| 5 years | +63.9% |
Signals
| 50-day / 200-day average | 1,454.40 / 1,383.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 89.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jul 2026 | IDR 10.0000 |
| 9 Jul 2025 | IDR 10.0000 |
| 8 Jul 2024 | IDR 8.0000 |
| 4 Jul 2023 | IDR 8.0000 |
| 27 Jun 2023 | IDR 100,000.0000 |
| 27 May 2019 | IDR 10.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.